○ “Gateway to Europe: Luxembourg Healthtech Business Seminar” hosted by the Gyeonggido Business & Science Accelerator on August 25
○ Introduction of Luxembourg’s healthtech ecosystem and one-on-one business meetings held for six companies
Gyeonggi Province has begun supporting local health technology companies in entering the European market by using Luxembourg as a gateway.
On August 25, Gyeonggi jointly hosted the healthtech business seminar “Gateway to Europe: Luxembourg Healthtech Business Seminar” at the Gyeonggi Bio Center with the Embassy of Luxembourg in Korea and the Gyeonggido Business & Science Accelerator.
The seminar was held to support bio and digital healthtech companies in the province in entering the European market by introducing the local market and industrial ecosystem, as well as the support environment for market entry, and by creating opportunities for exchanges with related institutions in Luxembourg. About 30 people attended the event, including Luxembourg officials and representatives of medical device and digital health companies in the province.
At the seminar, Koo Seon-mi, a senior commercial officer at the Embassy of Luxembourg in Korea, first introduced Luxembourg’s support system for entry to the European market. Regis Cire, head of healthtech at Luxinnovation, Luxembourg’s innovation support agency, then introduced Luxembourg’s healthtech and digital bio ecosystem, while Dr. Kim Hee-eun of the Luxembourg Institute of Health (LIH) explained the local health research environment and the institution’s role.
Nam Byung-ho, CEO of HERINGS, a company with experience entering the Luxembourg market, then shared the company’s experience, providing Gyeonggi-based companies with practical information for their own expansion into the European market.
After the seminar, exchanges and one-on-one business meetings were held between companies in the province and Luxembourg’s related institutions. The meetings were attended by six companies in the province, including Noul (AI-based in vitro diagnostics), iConnectome (precision medicine and genomics), Biner (digital health and wearable devices), BioNexus (AI bio data platform), 6Letters (digital health and hormone monitoring), and Julia Bionics (biohealth and medical AI). They introduced their technologies and business models to representatives of Luxinnovation and the Embassy of Luxembourg in Korea. They discussed their potential to enter the European market as well as possible local cooperation.
Eom Ki-man, Director of Gyeonggi Province’s Bio Industry Division, said, “Access to information on local regulations and certification, as well as securing local business partners, is important for medical device companies entering the European market. With its healthtech ecosystem and business support system, Luxembourg is well suited to serve as a gateway to Europe.” He added, “Building on our cooperation with Luxembourg, we will actively support local medical device SMEs in expanding into Europe and strengthening partnerships there.”